We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Potential New Tool for Cervical Cancer Detection

By LabMedica International staff writers
Posted on 29 Dec 2014
Image: Comparison of between normal cervical tissue (top), tissue lesion (second row), photographic image (third row) and corresponding DMAP images (fourth row) (Photo courtesy of Biomedical Optics Express).
Image: Comparison of between normal cervical tissue (top), tissue lesion (second row), photographic image (third row) and corresponding DMAP images (fourth row) (Photo courtesy of Biomedical Optics Express).
Photoacoustic imaging (PAI) has the potential to be a quicker, cheaper, and less-invasive method for detecting and staging cervical cancer (CC), according to a new study.

Researchers at Central South University (Changsha, China) conducted 30 in vitro experiments with tissue samples representing different cancer stages, using PAI, a hybrid optical imaging technique that combines the high contrast of pure optical imaging with the high spatial resolution and the deep imaging depth of ultrasound. The technique involves short laser pulses, some of which are absorbed by the tissues and converted into heat, leading to rapid thermal expansion inside the tissues that produces ultrasonic waves. The generated waves are then detected by an ultrasonic sensor to form photoacoustic images of the tissues.

In each of the experiments, the researchers embedded one section of normal cervical tissue and one section of cervical lesion (from the same person) in a cylindrical phantom for simultaneous PAI. Part of each sample was also sent to histological evaluation for cross-PAI. By processing all of the imaging data, the researchers obtained a depth maximum amplitude projection (DMAP) image, which shows the PAI contrast of the sample. The researchers used hemoglobin as the contrast agent, since PAI is highly sensitive to abnormal angiogenesis, a hallmark of CC tumors.

The obtained DMAP images were analyzed to evaluate the extent of the angiogenesis for different clinical stages of CC. The results showed stronger absorption from the cervical lesions, relative to that of normal tissue. The difference in mean optical absorption (MOA) between normal tissue and CC lesions showed a statistical significance, and the MOA of the CC lesions were closely related to the severity of CC. The study was published in the January 2015 issue of Biomedical Optics Express.

“Due to the higher hemoglobin concentration, abnormal angiogenesis has higher optical absorptions in certain wavelengths than normal tissues,” said lead author assistant professor of biomedical engineering Jiaying Xiao, PhD. “The technique is noninvasive and can detect the lesions in the cervical canal, an area conventional methods fail to observe. The photoacoustic imaging can also evaluate the invasion depth of cervical lesions more effectively.”

In current clinical practice, the diagnosis of CC is mainly through the cervical screening followed by a necessary biopsy, but this method is labor consuming and expensive, and can only detect superficial lesions around the external cervical orifice. In contrast, PAI is sensitive to the abnormal angiogenesis deep in the biological tissue, and may be capable for the intact scanning both around the external orifice and in cervical canal.

Related Links:

Central South University


Gold Member
Hybrid Pipette
SWITCH
POC Helicobacter Pylori Test Kit
Hepy Urease Test
8-Channel Pipette
SAPPHIRE 20–300 µL
Autoimmune Liver Diseases Assay
Microblot-Array Liver Profile Kit

Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more